These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 1601754)

  • 1. Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs.
    Muzzio M; Hu SC; Holleran JL; Parise RA; Eiseman JL; Yellow-Duke AE; Covey JM; Glaze ER; Engelke K; Egorin MJ; McCormick DL; Beumer JH
    Cancer Chemother Pharmacol; 2015 May; 75(5):1015-23. PubMed ID: 25776905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves.
    Rajput N; Dumka VK; Sandhu HS
    J Vet Sci; 2007 Mar; 8(1):21-5. PubMed ID: 17322770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaling basic toxicokinetic parameters from rat to man.
    Bachmann K; Pardoe D; White D
    Environ Health Perspect; 1996 Apr; 104(4):400-7. PubMed ID: 8732950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefpirome (HR 810), a new cephalosporin derivative administered intramuscularly and intravenously to healthy volunteers.
    Maass L; Malerczyk V; Verho M
    Infection; 1987; 15(3):207-10. PubMed ID: 3610329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerance and pharmacokinetics of cefpirome administered intramuscularly to healthy subjects.
    Meyer BH; Muller FO; Luus HG; Drees B; Röthig HJ; Badian M; Eckert HG
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():63-70. PubMed ID: 1601759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and ex-vivo pharmacodynamics of cefquinome against Klebsiella pneumonia in healthy dogs.
    Zhang B; Gu X; Li X; Gu M; Zhang N; Shen X; Li Y; Ding H
    J Vet Pharmacol Ther; 2014 Aug; 37(4):367-73. PubMed ID: 24372291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs.
    Zhou YF; Zhao DH; Yu Y; Yang X; Shi W; Peng YB; Liu YH
    J Vet Pharmacol Ther; 2015 Dec; 38(6):543-8. PubMed ID: 25776615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs.
    Isert D; Klesel N; Limbert M; Markus A; Seibert G; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():31-7. PubMed ID: 1601754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single- and multiple-dose pharmacokinetics of intravenous cefpirome (HR810) to healthy volunteers.
    Nakayama I; Akieda Y; Yamaji E; Nitta Y; Ohishi M; Katagiri K; Imamura N; Takase K
    J Clin Pharmacol; 1992 Mar; 32(3):256-66. PubMed ID: 1564130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefpirome clinical pharmacokinetics.
    Strenkoski LC; Nix DE
    Clin Pharmacokinet; 1993 Oct; 25(4):263-73. PubMed ID: 8261711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the pharmacokinetics of cefepime in children.
    Blumer JL; Reed MD; Knupp C
    Pediatr Infect Dis J; 2001 Mar; 20(3):337-42. PubMed ID: 11303847
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.